Home Doc Lobe Body and Brain
Doc LobeTeaching, Learning & Research Firm
Interactive model

Body and Brain

Mental disorders are not only "in the head." Switch between a male and a female body, pick a condition, and see which parts of the brain, nervous system and body it affects, then follow the stress hormone system (the HPA axis) and the diathesis-stress model that links vulnerability and stress.

For learning only. These are group-average research findings shown on a simplified model. They are not signs you can see in one person, and they cannot be used to diagnose anyone.

Drag to turn · hover a part to learn what it does
BrainSpinal cord and nervesVagus nerveSympathetic chainReproductive organsAffected by the chosen condition
Female and male bodies

Why sex differences matter

Switch between the male and female body at the top of the model. The brain, nervous system and organs are the same on both. The female body is the same anatomical model reshaped (shoulders, waist, hips, chest and pelvis) with female reproductive organs, so the differences you see are in hormones, reproductive organs and how often each condition appears. Open the Female vs. male tab for each condition.

Sex and gender are not the same thing. Sex is biological: chromosomes, hormones, anatomy and physiology. Gender covers identity, expression and the social expectations placed on people. Both can shape who develops a disorder, how it shows up and how it is treated.

Sex hormones change across the lifespan. Estrogen and progesterone rise at puberty, cycle each month, surge in pregnancy, drop sharply after birth and fall again in perimenopause. These are the same windows when some women first develop, or see a worsening of, depression, anxiety and other conditions. In some people the brain seems unusually sensitive to these normal shifts.

The stress system (the HPA axis: hypothalamus, pituitary, adrenal glands) talks to the sex-hormone system. In animal studies, estradiol tends to boost the stress-hormone response, while testosterone tends to damp it down. This may help explain why depression and anxiety are more common in women.

For decades, research leaned on male animals, male cells and, before the 1990s, often left women out of clinical trials. A 1977 FDA guideline kept women of childbearing potential out of early drug trials. The NIH Revitalization Act of 1993 made including women in NIH clinical research a legal requirement, and since January 2016 the NIH Sex as a Biological Variable policy expects researchers to factor sex into the design, analysis and reporting of animal and human studies.

This page uses a simplified two-body teaching model. Real people are more varied. Some people are intersex, with sex traits that do not fit typical male or female patterns (about 1.7% by one estimate, though estimates vary), and transgender people may have hormone levels or anatomy that differ from what either model shows. NIH notes that intersex and transgender people have often been left out of research, so much less is known about them.

Sources for female and male differences (67)
  1. National Institutes of Health, Office of Research on Women's Health. (n.d.). NIH policy on sex as a biological variable. U.S. Department of Health and Human Services.
  2. National Institutes of Health, Office of Research on Women's Health. (n.d.). Sex & gender. U.S. Department of Health and Human Services.
  3. National Institutes of Health, Office of Research on Women's Health. (n.d.). History of women's participation in clinical research. U.S. Department of Health and Human Services.
  4. Clayton, J. A., & Collins, F. S. (2014). Policy: NIH to balance sex in cell and animal studies. Nature, 509(7500), 282-283. https://doi.org/10.1038/509282a
  5. Heck, A. L., & Handa, R. J. (2019). Sex differences in the hypothalamic-pituitary-adrenal axis' response to stress: An important role for gonadal hormones. Neuropsychopharmacology, 44(1), 45-58. https://doi.org/10.1038/s41386-018-0167-9
  6. National Institute of Mental Health. (n.d.). Depression in women: 4 things to know. U.S. Department of Health and Human Services.
  7. National Institute of Mental Health. (n.d.). Major depression [Statistics]. U.S. Department of Health and Human Services.
  8. Chand, S. P., & Arif, H. (2023). Depression. In StatPearls. StatPearls Publishing.
  9. National Institute of Mental Health. (n.d.). Perinatal depression. U.S. Department of Health and Human Services.
  10. Carlson, K., Mughal, S., Azhar, Y., & Siddiqui, W. (2025). Perinatal depression. In StatPearls. StatPearls Publishing.
  11. Miller, C., & Carlson, K. (2026). Premenstrual disorders. In StatPearls. StatPearls Publishing.
  12. Badawy, Y., Spector, A., Li, Z., & Desai, R. (2024). The risk of depression in the menopausal stages: A systematic review and meta-analysis. Journal of Affective Disorders, 357, 126-133. https://doi.org/10.1016/j.jad.2024.04.041
  13. Mu, E., Chiu, L., & Kulkarni, J. (2025). Using estrogen and progesterone to treat premenstrual dysphoric disorder, postnatal depression and menopausal depression. Frontiers in Pharmacology, 16, 1528544. https://doi.org/10.3389/fphar.2025.1528544
  14. Infante-Cano, M., García-Muñoz, C., Matias-Soto, J., et al. (2025). The prevalence and risk of anxiety and depression in polycystic ovary syndrome: An overview of systematic reviews with meta-analysis. Archives of Women's Mental Health, 28, 475-489. https://doi.org/10.1007/s00737-024-01526-1
  15. Centers for Disease Control and Prevention. (n.d.). Suicide data and statistics. U.S. Department of Health and Human Services.
  16. National Institute of Mental Health. (n.d.). Men and mental health. U.S. Department of Health and Human Services.
  17. Lewkowitz, A. K., & Miller, E. S. (2025, September 3). Getting the facts straight: Pregnancy, depression, and SSRIs. Society for Maternal-Fetal Medicine.
  18. National Institute of Mental Health. (n.d.). Generalized anxiety disorder [Statistics]. U.S. Department of Health and Human Services.
  19. Munir, S., & Takov, V. (2022). Generalized anxiety disorder. In StatPearls. StatPearls Publishing.
  20. Green, S. A., & Graham, B. M. (2022). Symptom fluctuation over the menstrual cycle in anxiety disorders, PTSD, and OCD: A systematic review. Archives of Women's Mental Health, 25(1), 71-85. https://doi.org/10.1007/s00737-021-01187-4
  21. National Institute of Mental Health. (n.d.). Panic disorder [Statistics]. U.S. Department of Health and Human Services.
  22. Cackovic, C., Nazir, S., & Marwaha, R. (2023). Panic disorder. In StatPearls. StatPearls Publishing.
  23. National Institute of Mental Health. (n.d.). Post-traumatic stress disorder (PTSD) [Statistics]. U.S. Department of Health and Human Services.
  24. U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). How common is PTSD in adults?
  25. Eder-Moreau, E., Zhu, X., Fisch, C. T., Bergman, M., & Neria, Y. (2022). Neurobiological alterations in females with PTSD: A systematic review. Frontiers in Psychiatry, 13, 862476. https://doi.org/10.3389/fpsyt.2022.862476
  26. Mu, E., Thomas, E. H. X., & Kulkarni, J. (2022). Menstrual cycle in trauma-related disorders: A mini-review. Frontiers in Global Women's Health, 3, 910220. https://doi.org/10.3389/fgwh.2022.910220
  27. National Institute of Mental Health. (n.d.). Obsessive-compulsive disorder (OCD) [Statistics]. U.S. Department of Health and Human Services.
  28. Brock, H., Rizvi, A., & Hany, M. (2024). Obsessive-compulsive disorder. In StatPearls. StatPearls Publishing.
  29. Mathes, B. M., Morabito, D. M., & Schmidt, N. B. (2019). Epidemiological and clinical gender differences in OCD. Current Psychiatry Reports, 21, 36. https://doi.org/10.1007/s11920-019-1015-2
  30. National Institute of Mental Health. (n.d.). Bipolar disorder [Statistics]. U.S. Department of Health and Human Services.
  31. Jain, A., & Mitra, P. (2023). Bipolar disorder. In StatPearls. StatPearls Publishing.
  32. Slyepchenko, A., Minuzzi, L., & Frey, B. N. (2021). Comorbid premenstrual dysphoric disorder and bipolar disorder: A review. Frontiers in Psychiatry, 12, 719241. https://doi.org/10.3389/fpsyt.2021.719241
  33. Wesseloo, R., Kamperman, A. M., Munk-Olsen, T., Pop, V. J., Kushner, S. A., & Bergink, V. (2016). Risk of postpartum relapse in bipolar disorder and postpartum psychosis: A systematic review and meta-analysis. American Journal of Psychiatry, 173(2), 117-127. https://doi.org/10.1176/appi.ajp.2015.15010124
  34. Fornaro, M., Maritan, E., Ferranti, R., et al. (2020). Lithium exposure during pregnancy and the postpartum period: A systematic review and meta-analysis of safety and efficacy outcomes. American Journal of Psychiatry, 177(1), 76-92. https://doi.org/10.1176/appi.ajp.2019.19030228
  35. Holmskov, M., Christensen, J., Larsen, M. F., Christiansen, A. E., & Nielsen, R. E. (2026). Polycystic ovary syndrome in women with bipolar affective disorder or epilepsy exposed to valproic acid: A nationwide 16-year cohort study. International Journal of Bipolar Disorders, 14, 6. https://doi.org/10.1186/s40345-026-00411-3
  36. Hany, M., & Rizvi, A. (2024). Schizophrenia. In StatPearls. StatPearls Publishing.
  37. Moniem, I., & Kafetzopoulos, V. (2025). Sex differences in schizophrenia: Symptomatology, treatment efficacy and adverse effects. Frontiers in Psychiatry, 16, 1594334. https://doi.org/10.3389/fpsyt.2025.1594334
  38. Centers for Disease Control and Prevention. (n.d.). Data and statistics on ADHD. U.S. Department of Health and Human Services.
  39. Young, S., Adamo, N., Ásgeirsdóttir, B. B., et al. (2020). Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/hyperactivity disorder in girls and women. BMC Psychiatry, 20, 404. https://doi.org/10.1186/s12888-020-02707-9
  40. Kooij, J. J. S., de Jong, M., Agnew-Blais, J., et al. (2025). Research advances and future directions in female ADHD: The lifelong interplay of hormonal fluctuations with mood, cognition, and disease. Frontiers in Global Women's Health, 6, 1613628. https://doi.org/10.3389/fgwh.2025.1613628
  41. Centers for Disease Control and Prevention. (n.d.). Data and statistics on autism spectrum disorder. U.S. Department of Health and Human Services.
  42. Hull, L., Petrides, K. V., & Mandy, W. (2020). The female autism phenotype and camouflaging: A narrative review. Review Journal of Autism and Developmental Disorders, 7(4), 306-317. https://doi.org/10.1007/s40489-020-00197-9
  43. National Institute of Mental Health. (n.d.). Eating disorders [Statistics]. U.S. Department of Health and Human Services.
  44. Moore, C. A., & Bokor, B. R. (2023). Anorexia nervosa. In StatPearls. StatPearls Publishing.
  45. Haines, M. S. (2023). Endocrine complications of anorexia nervosa. Journal of Eating Disorders, 11, 24. https://doi.org/10.1186/s40337-023-00744-9
  46. Fazeli, P. K., & Klibanski, A. (2018). Effects of anorexia nervosa on bone metabolism. Endocrine Reviews, 39(6), 895-910. https://doi.org/10.1210/er.2018-00063
  47. National Institute on Alcohol Abuse and Alcoholism. (n.d.). Women and alcohol [Fact sheet]. National Institutes of Health.
  48. National Institute on Alcohol Abuse and Alcoholism. (n.d.). Alcohol use disorder (AUD) in the United States: Age groups and demographic characteristics. National Institutes of Health.
  49. National Institute on Drug Abuse. (n.d.). Sex and gender differences in substance use. In Substance use in women research report. National Institutes of Health.
  50. National Academies of Sciences, Engineering, and Medicine. (2024). Chronic conditions that predominantly impact or affect women differently. In Z. Batulan, A. Bhimla, & E. J. Higginbotham (Eds.), Advancing research on chronic conditions in women. National Academies Press.
  51. Centers for Disease Control and Prevention. (n.d.). About fetal alcohol spectrum disorders (FASDs). U.S. Department of Health and Human Services.
  52. Emanuele, M. A., & Emanuele, N. V. (1998). Alcohol's effects on male reproduction. Alcohol Health & Research World, 22(3), 195-201.
  53. Centers for Disease Control and Prevention. (n.d.). About opioid use during pregnancy. U.S. Department of Health and Human Services.
  54. Garnett, M. F., & Miniño, A. M. (2026). Drug overdose deaths in the United States, 2023-2024 (NCHS Data Brief No. 549). National Center for Health Statistics.
  55. Coluzzi, F., Billeci, D., Maggi, M., & Corona, G. (2018). Testosterone deficiency in non-cancer opioid-treated patients. Journal of Endocrinological Investigation, 41(12), 1377-1388. https://doi.org/10.1007/s40618-018-0964-3
  56. Fonseca, F., Robles-Martínez, M., Tirado-Muñoz, J., et al. (2021). A gender perspective of addictive disorders. Current Addiction Reports, 8(1), 89-99. https://doi.org/10.1007/s40429-021-00357-9
  57. Brabete, A. C., Greaves, L., Hemsing, N., & Stinson, J. (2020). Sex- and gender-based analysis in cannabis treatment outcomes: A systematic review. International Journal of Environmental Research and Public Health, 17(3), 872. https://doi.org/10.3390/ijerph17030872
  58. Centers for Disease Control and Prevention. (n.d.). Cannabis and pregnancy [Health effects]. U.S. Department of Health and Human Services.
  59. Nimmana, B. K., Aslam, S. P., & Marwaha, R. (2026). Cannabis use disorder. In StatPearls. StatPearls Publishing.
  60. Chapman, J., Jamil, R. T., Fleisher, C., & Torrico, T. J. (2024). Borderline personality disorder. In StatPearls. StatPearls Publishing.
  61. Qian, X., Townsend, M. L., Tan, W. J., & Grenyer, B. F. S. (2022). Sex differences in borderline personality disorder: A scoping review. PLOS ONE, 17(12), e0279015. https://doi.org/10.1371/journal.pone.0279015
  62. Bozzatello, P., Blua, C., Brandellero, D., Baldassarri, L., Brasso, C., Rocca, P., & Bellino, S. (2024). Gender differences in borderline personality disorder: A narrative review. Frontiers in Psychiatry, 15, 1320546. https://doi.org/10.3389/fpsyt.2024.1320546
  63. Eisenlohr-Moul, T. A., Schmalenberger, K. M., Owens, S. A., Peters, J. R., Dawson, D. N., & Girdler, S. S. (2018). Perimenstrual exacerbation of symptoms in borderline personality disorder: Evidence from multilevel models and the Carolina Premenstrual Assessment Scoring System. Psychological Medicine, 48(12), 2085-2095. https://doi.org/10.1017/S0033291718001253
  64. Zhang, B., & Wing, Y.-K. (2006). Sex differences in insomnia: A meta-analysis. Sleep, 29(1), 85-93. https://doi.org/10.1093/sleep/29.1.85
  65. McNamara, S., Spurling, B. C., & Bollu, P. C. (2025). Chronic insomnia. In StatPearls. StatPearls Publishing.
  66. Troìa, L., Garassino, M., Volpicelli, A. I., et al. (2025). Sleep disturbance and perimenopause: A narrative review. Journal of Clinical Medicine, 14(5), 1479. https://doi.org/10.3390/jcm14051479
  67. U.S. Food and Drug Administration. (2013, May 14). FDA Drug Safety Communication: FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR.
Stress hormones

The HPA axis

The HPA axis is the body's slower stress system. The hypothalamus signals the pituitary, which signals the adrenal glands to release cortisol. Cortisol helps the body handle stress and then shuts the system off through negative feedback.

Press play, or pick a step, to follow the signal from the brain to the adrenal glands and back.

Compare stress patterns

Illustrative shapes based on the research summaries, not real lab units.

Fast and slow stress systems

The SAM (sympathetic-adrenal-medullary) pathway is the fast stress system. Within seconds, sympathetic nerves signal the adrenal medulla to release adrenaline (epinephrine) and noradrenaline, which raise heart rate and breathing. The HPA axis is slower: cortisol peaks in about 20 to 30 minutes and lasts longer.

What cortisol does

  • Raises blood sugar to give the body quick energy.
  • Reduces inflammation and immune activity in the short term; long-term exposure can make immune cells resist cortisol.
  • Raises blood pressure and supports the heart's response to stress.
  • Suppresses digestion, growth, and reproductive hormones during stress.
  • Affects memory: short bursts can strengthen emotional memories, while long-term high levels can harm hippocampal neurons in animal studies.
  • Long-term high levels are linked to belly fat, muscle and bone loss, and poor sleep.

Allostatic load

Bruce McEwen used the term 'allostasis' for how the body adapts to stress by changing its set points. 'Allostatic load' is the wear and tear that builds up when stress systems are turned on too often, stay on too long, or do not shut off. Over time this load is linked to heart disease, obesity, diabetes, and brain changes.

Why some people and not others?

The diathesis-stress model

The diathesis-stress model says mental disorders develop when a person with a vulnerability (diathesis) faces enough stress. Zubin and Spring (1977) described vulnerability to schizophrenia this way, and Monroe and Simons (1991) applied it to depression. The differential susceptibility model (Belsky and Pluess) adds that some traits make people more sensitive to both bad and good environments. The biopsychosocial model (Engel) says biology, psychology, and social factors all interact. A stress-vulnerability-protective model adds that protective factors can lower risk.

Each person has a threshold. The more vulnerable a person is, the less stress it takes to cross that threshold and develop a disorder. A person with low vulnerability may need a lot of stress before symptoms appear. Protective factors raise the threshold. The dashed line shows the threshold with no protective factors.

Diathesis (vulnerability)

  • Genes and family history
  • Early adversity such as abuse or neglect
  • Temperament, such as high neuroticism or behavioral inhibition
  • Cognitive style, such as negative thinking patterns
  • Brain differences present before illness

Stressors

  • Loss of a loved one
  • Trauma or violence
  • Chronic stress such as poverty or discrimination
  • Major life changes such as moving or starting college
  • Substance use
  • Sleep loss

Protective factors

  • Social support
  • Coping skills
  • Healthy sleep
  • Exercise
  • Access to treatment
  • Stable housing and income

Try an example

Limits of the model

The model is broad and hard to test because vulnerability and stress are hard to measure separately. Stress can also be caused by the disorder itself (for example, depression can cause job loss). Differential susceptibility suggests the model misses how vulnerable people can also do better than others in supportive environments. Genes and environment interact in complex ways that simple threshold models do not capture.

Learn more

Videos and sources

▶ Watch

📖 Read (open access)

All references (77)
  1. Bahji, A., Stephenson, C., Tyo, R., Hawken, E. R., & Seitz, D. P. (2020). Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: A systematic review and meta-analysis. JAMA Network Open, 3(4), e202370. https://pmc.ncbi.nlm.nih.gov/articles/PMC7146100/
  2. Belsky, J., & Pluess, M. (2009). Beyond diathesis stress: Differential susceptibility to environmental influences. Psychological Bulletin, 135(6), 885-908. https://doi.org/10.1037/a0017376
  3. Belvederi Murri, M., Prestia, D., Mondelli, V., Pariante, C., Patti, S., Olivieri, B., Arzani, C., et al. (2016). The HPA axis in bipolar disorder: Systematic review and meta-analysis. Psychoneuroendocrinology, 63, 327-342. https://doi.org/10.1016/j.psyneuen.2015.10.014
  4. Boedhoe, P. S., Schmaal, L., Abe, Y., Ameis, S. H., Arnold, P. D., Batistuzzo, M. C., Benedetti, F., et al. (2017). Distinct subcortical volume alterations in pediatric and adult OCD: A worldwide meta- and mega-analysis. American Journal of Psychiatry, 174(1), 60-69. https://pmc.ncbi.nlm.nih.gov/articles/PMC5344782/
  5. Brock, H., Rizvi, A., & Hany, M. (2024). Obsessive-compulsive disorder. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK553162/
  6. Cackovic, C., Nazir, S., & Marwaha, R. (2023). Panic disorder. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430973/
  7. Chalmers, J. A., Quintana, D. S., Abbott, M. J., & Kemp, A. H. (2014). Anxiety disorders are associated with reduced heart rate variability: A meta-analysis. Frontiers in Psychiatry, 5, 80. https://pmc.ncbi.nlm.nih.gov/articles/PMC4092363/
  8. Chand, S. P., & Arif, H. (2023). Depression. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430847/
  9. Chapman, J., Jamil, R. T., Fleisher, C., & Torrico, T. J. (2024). Borderline personality disorder. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430883/
  10. Chu, B., Marwaha, K., Sanvictores, T., Awosika, A. O., & Ayers, D. (2024). Physiology, stress reaction. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK541120/
  11. Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., et al. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877-2013. https://doi.org/10.1152/physrev.00018.2018
  12. Drevets, W. C., Price, J. L., & Furey, M. L. (2008). Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Structure and Function, 213(1-2), 93-118. https://pmc.ncbi.nlm.nih.gov/articles/PMC2522333/
  13. Drews, E., Fertuck, E. A., Koenig, J., Kaess, M., & Arntz, A. (2019). Hypothalamic-pituitary-adrenal axis functioning in borderline personality disorder: A meta-analysis. Neuroscience & Biobehavioral Reviews, 96, 316-334. https://doi.org/10.1016/j.neubiorev.2018.11.008
  14. Dydyk, A. M., Jain, N. K., & Gupta, M. (2024). Opioid use disorder: Evaluation and management. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK553166/
  15. Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129-136. https://doi.org/10.1126/science.847460
  16. Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., et al. (2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789-818. https://pmc.ncbi.nlm.nih.gov/articles/PMC8328933/
  17. Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016). A meta-analysis of blood cytokine network alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder and depression. Molecular Psychiatry, 21(12), 1696-1709. https://pmc.ncbi.nlm.nih.gov/articles/PMC6056174/
  18. Gorman, J. M., Kent, J. M., Sullivan, G. M., & Coplan, J. D. (2000). Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry, 157(4), 493-505. https://doi.org/10.1176/appi.ajp.157.4.493
  19. Hany, M., & Rizvi, A. (2024). Schizophrenia. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK539864/
  20. Harrewijn, A., Cardinale, E. M., Groenewold, N. A., Bas-Hoogendam, J. M., Aghajani, M., Hilbert, K., Cardoner, N., et al. (2021). Cortical and subcortical brain structure in generalized anxiety disorder: Findings from 28 research sites in the ENIGMA-Anxiety Working Group. Translational Psychiatry, 11(1), 502. https://pmc.ncbi.nlm.nih.gov/articles/PMC8486763/
  21. Harrison, P. J., Geddes, J. R., & Tunbridge, E. M. (2018). The emerging neurobiology of bipolar disorder. Trends in Neurosciences, 41(1), 18-30. https://pmc.ncbi.nlm.nih.gov/articles/PMC5755726/
  22. Herman, J. P., McKlveen, J. M., Ghosal, S., Kopp, B., Wulsin, A., Makinson, R., Scheimann, J., & Myers, B. (2016). Regulation of the hypothalamic-pituitary-adrenocortical stress response. Comprehensive Physiology, 6(2), 603-621. https://pmc.ncbi.nlm.nih.gov/articles/PMC4867107/
  23. Hibar, D. P., Westlye, L. T., Doan, N. T., Jahanshad, N., Cheung, J. W., Ching, C. R. K., Versace, A., et al. (2018). Cortical abnormalities in bipolar disorder: An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Molecular Psychiatry, 23(4), 932-942. https://pmc.ncbi.nlm.nih.gov/articles/PMC5668195/
  24. Hibar, D. P., Westlye, L. T., van Erp, T. G. M., Rasmussen, J., Leonardo, C. D., Faskowitz, J., Haukvik, U. K., et al. (2016). Subcortical volumetric abnormalities in bipolar disorder. Molecular Psychiatry, 21(12), 1710-1716. https://pmc.ncbi.nlm.nih.gov/articles/PMC5116479/
  25. Hilbert, K., Lueken, U., & Beesdo-Baum, K. (2014). Neural structures, functioning and connectivity in generalized anxiety disorder and interaction with neuroendocrine systems: A systematic review. Journal of Affective Disorders, 158, 114-126. https://doi.org/10.1016/j.jad.2014.01.022
  26. Hodis, B., Mughal, S., & Saadabadi, A. (2025). Autism spectrum disorder. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK525976/
  27. Hoogman, M., Bralten, J., Hibar, D. P., Mennes, M., Zwiers, M. P., Schweren, L. S. J., van Hulzen, K. J. E., et al. (2017). Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: A cross-sectional mega-analysis. The Lancet Psychiatry, 4(4), 310-319. https://pmc.ncbi.nlm.nih.gov/articles/PMC5933934/
  28. Howes, O. D., & Kapur, S. (2009). The dopamine hypothesis of schizophrenia: Version III. The final common pathway. Schizophrenia Bulletin, 35(3), 549-562. https://pmc.ncbi.nlm.nih.gov/articles/PMC2669582/
  29. Jain, A., & Mitra, P. (2023). Bipolar disorder. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK558998/
  30. Kelly, S., Jahanshad, N., Zalesky, A., Kochunov, P., Agartz, I., Alloza, C., Andreassen, O. A., et al. (2018). Widespread white matter microstructural differences in schizophrenia across 4322 individuals: Results from the ENIGMA Schizophrenia DTI Working Group. Molecular Psychiatry, 23(5), 1261-1269. https://pmc.ncbi.nlm.nih.gov/articles/PMC5984078/
  31. Koch, C., Wilhelm, M., Salzmann, S., Rief, W., & Euteneuer, F. (2019). A meta-analysis of heart rate variability in major depression. Psychological Medicine, 49(12), 1948-1957. https://doi.org/10.1017/S0033291719001351
  32. Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: A neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760-773. https://pmc.ncbi.nlm.nih.gov/articles/PMC6135092/
  33. Leichsenring, F., Heim, N., Leweke, F., Spitzer, C., Steinert, C., & Kernberg, O. F. (2023). Borderline personality disorder: A review. JAMA, 329(8), 670-679. https://doi.org/10.1001/jama.2023.0589
  34. Logue, M. W., van Rooij, S. J. H., Dennis, E. L., Davis, S. L., Hayes, J. P., Stevens, J. S., Densmore, M., et al. (2018). Smaller hippocampal volume in posttraumatic stress disorder: A multisite ENIGMA-PGC study. Biological Psychiatry, 83(3), 244-253. https://pmc.ncbi.nlm.nih.gov/articles/PMC5951719/
  35. Lord, C., Brugha, T. S., Charman, T., Cusack, J., Dumas, G., Frazier, T., Jones, E. J. H., et al. (2020). Autism spectrum disorder. Nature Reviews Disease Primers, 6(1), 5. https://pmc.ncbi.nlm.nih.gov/articles/PMC8900942/
  36. Lorenzetti, V., Chye, Y., Silva, P., Solowij, N., & Roberts, C. A. (2019). Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies. European Archives of Psychiatry and Clinical Neuroscience, 269(1), 59-71. https://doi.org/10.1007/s00406-019-00979-1
  37. Mackey, S., Allgaier, N., Chaarani, B., Spechler, P., Orr, C., Bunn, J., Allen, N. B., et al. (2019). Mega-analysis of gray matter volume in substance dependence: General and substance-specific regional effects. American Journal of Psychiatry, 176(2), 119-128. https://pmc.ncbi.nlm.nih.gov/articles/PMC6427822/
  38. Magnus, W., Anilkumar, A. C., & Shaban, K. (2023). Attention deficit hyperactivity disorder. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK441838/
  39. McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020). Schizophrenia: An overview. JAMA Psychiatry, 77(2), 201-210. https://doi.org/10.1001/jamapsychiatry.2019.3360
  40. McElhanon, B. O., McCracken, C., Karpen, S., & Sharp, W. G. (2014). Gastrointestinal symptoms in autism spectrum disorder: A meta-analysis. Pediatrics, 133(5), 872-883. https://doi.org/10.1542/peds.2013-3995
  41. McEwen, B. S. (1998). Protective and damaging effects of stress mediators. New England Journal of Medicine, 338(3), 171-179. https://doi.org/10.1056/NEJM199801153380307
  42. McNamara, S., Spurling, B. C., & Bollu, P. C. (2025). Chronic insomnia. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK526136/
  43. Mehler, P. S., & Brown, C. (2015). Anorexia nervosa: Medical complications. Journal of Eating Disorders, 3, 11. https://pmc.ncbi.nlm.nih.gov/articles/PMC4381361/
  44. Monroe, S. M., & Simons, A. D. (1991). Diathesis-stress theories in the context of life stress research: Implications for the depressive disorders. Psychological Bulletin, 110(3), 406-425. https://doi.org/10.1037/0033-2909.110.3.406
  45. Moore, C. A., & Bokor, B. R. (2023). Anorexia nervosa. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459148/
  46. Morris, M. C., Compas, B. E., & Garber, J. (2012). Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: A systematic review and meta-analysis. Clinical Psychology Review, 32(4), 301-315. https://pmc.ncbi.nlm.nih.gov/articles/PMC3340453/
  47. Munir, S., & Takov, V. (2022). Generalized anxiety disorder. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK441870/
  48. National Institute of Mental Health. (n.d.). Borderline personality disorder. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/topics/borderline-personality-disorder
  49. National Institute of Mental Health. (n.d.). Traumatic events and post-traumatic stress disorder (PTSD). U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd
  50. National Institute on Alcohol Abuse and Alcoholism. (n.d.). Alcohol's effects on the body. National Institutes of Health. https://www.niaaa.nih.gov/alcohols-effects-health/alcohols-effects-body
  51. Nehring, S. M., Chen, R. J., & Freeman, A. M. (2024). Alcohol use disorder: Screening, evaluation, and management. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK436003/
  52. Nimmana, B. K., Aslam, S. P., & Marwaha, R. (2026). Cannabis use disorder. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538131/
  53. Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020). Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain, Behavior, and Immunity, 87, 901-909. https://pmc.ncbi.nlm.nih.gov/articles/PMC7327519/
  54. Pariante, C. M., & Lightman, S. L. (2008). The HPA axis in major depression: Classical theories and new developments. Trends in Neurosciences, 31(9), 464-468. https://doi.org/10.1016/j.tins.2008.06.006
  55. Pattinson, K. T. S. (2008). Opioids and the control of respiration. British Journal of Anaesthesia, 100(6), 747-758. https://doi.org/10.1093/bja/aen094
  56. Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014). Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective. Nature Reviews Neuroscience, 15(6), 410-424. https://doi.org/10.1038/nrn3746
  57. Pillinger, T., Beck, K., Gobjila, C., Donocik, J. G., Jauhar, S., & Howes, O. D. (2017). Impaired glucose homeostasis in first-episode schizophrenia: A systematic review and meta-analysis. JAMA Psychiatry, 74(3), 261-269. https://pmc.ncbi.nlm.nih.gov/articles/PMC6352957/
  58. Pitman, R. K., Rasmusson, A. M., Koenen, K. C., Shin, L. M., Orr, S. P., Gilbertson, M. W., Milad, M. R., & Liberzon, I. (2012). Biological studies of post-traumatic stress disorder. Nature Reviews Neuroscience, 13(11), 769-787. https://pmc.ncbi.nlm.nih.gov/articles/PMC4951157/
  59. Riemann, D., Nissen, C., Palagini, L., Otte, A., Perlis, M. L., & Spiegelhalder, K. (2015). The neurobiology, investigation, and treatment of chronic insomnia. The Lancet Neurology, 14(5), 547-558. https://doi.org/10.1016/S1474-4422(15)00021-6
  60. Ruocco, A. C., Amirthavasagam, S., Choi-Kain, L. W., & McMain, S. F. (2013). Neural correlates of negative emotionality in borderline personality disorder: An activation-likelihood-estimation meta-analysis. Biological Psychiatry, 73(2), 153-160. https://doi.org/10.1016/j.biopsych.2012.07.014
  61. Schmaal, L., Hibar, D. P., Sämann, P. G., Hall, G. B., Baune, B. T., Jahanshad, N., Cheung, J. W., et al. (2017). Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Molecular Psychiatry, 22(6), 900-909. https://pmc.ncbi.nlm.nih.gov/articles/PMC5444023/
  62. Schmaal, L., Veltman, D. J., van Erp, T. G. M., Sämann, P. G., Frodl, T., Jahanshad, N., Loehrer, E., et al. (2016). Subcortical brain alterations in major depressive disorder: Findings from the ENIGMA Major Depressive Disorder working group. Molecular Psychiatry, 21(6), 806-812. https://pmc.ncbi.nlm.nih.gov/articles/PMC4879183/
  63. Schulze, L., Schmahl, C., & Niedtfeld, I. (2016). Neural correlates of disturbed emotion processing in borderline personality disorder: A multimodal meta-analysis. Biological Psychiatry, 79(2), 97-106. https://doi.org/10.1016/j.biopsych.2015.03.027
  64. Stetler, C., & Miller, G. E. (2011). Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosomatic Medicine, 73(2), 114-126. https://doi.org/10.1097/PSY.0b013e31820ad12b
  65. Takamiya, A., Chung, J. K., Liang, K. C., Graff-Guerrero, A., Mimura, M., & Kishimoto, T. (2018). Effect of electroconvulsive therapy on hippocampal and amygdala volumes: Systematic review and meta-analysis. The British Journal of Psychiatry, 212(1), 19-26. https://doi.org/10.1192/bjp.2017.11
  66. Treasure, J., Duarte, T. A., & Schmidt, U. (2020). Eating disorders. The Lancet, 395(10227), 899-911. https://doi.org/10.1016/S0140-6736(20)30059-3
  67. van Erp, T. G. M., Hibar, D. P., Rasmussen, J. M., Glahn, D. C., Pearlson, G. D., Andreassen, O. A., Agartz, I., et al. (2016). Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry, 21(4), 547-553. https://pmc.ncbi.nlm.nih.gov/articles/PMC4668237/
  68. van Erp, T. G. M., Walton, E., Hibar, D. P., Schmaal, L., Jiang, W., Glahn, D. C., Pearlson, G. D., et al. (2018). Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biological Psychiatry, 84(9), 644-654. https://pmc.ncbi.nlm.nih.gov/articles/PMC6177304/
  69. van Rooij, D., Anagnostou, E., Arango, C., Auzias, G., Behrmann, M., Busatto, G. F., Calderoni, S., et al. (2018). Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: Results from the ENIGMA ASD Working Group. American Journal of Psychiatry, 175(4), 359-369. https://pmc.ncbi.nlm.nih.gov/articles/PMC6546164/
  70. van Velzen, L. S., Kelly, S., Isaev, D., Aleman, A., Aftanas, L. I., Bauer, J., Baune, B. T., et al. (2020). White matter disturbances in major depressive disorder: A coordinated analysis across 20 international cohorts in the ENIGMA MDD working group. Molecular Psychiatry, 25(7), 1511-1525. https://pmc.ncbi.nlm.nih.gov/articles/PMC7055351/
  71. Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219-2227. https://pmc.ncbi.nlm.nih.gov/articles/PMC4827335/
  72. Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine, 374(4), 363-371. https://pmc.ncbi.nlm.nih.gov/articles/PMC6135257/
  73. Volkow, N. D., Wang, G.-J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., et al. (2009). Evaluating dopamine reward pathway in ADHD: Clinical implications. JAMA, 302(10), 1084-1091. https://pmc.ncbi.nlm.nih.gov/articles/PMC2958516/
  74. Walton, E., Bernardoni, F., Batury, V. L., Bahnsen, K., Larivière, S., Abbate-Daga, G., Andrés-Perpiñá, S., et al. (2022). Brain structure in acutely underweight and partially weight-restored individuals with anorexia nervosa: A coordinated analysis by the ENIGMA Eating Disorders Working Group. Biological Psychiatry, 92(9), 730-738. https://doi.org/10.1016/j.biopsych.2022.04.022
  75. Yehuda, R., Hoge, C. W., McFarlane, A. C., Vermetten, E., Lanius, R. A., Nievergelt, C. M., Hobfoll, S. E., Koenen, K. C., Neylan, T. C., & Hyman, S. E. (2015). Post-traumatic stress disorder. Nature Reviews Disease Primers, 1, 15057. https://doi.org/10.1038/nrdp.2015.57
  76. Zorn, J. V., Schür, R. R., Boks, M. P., Kahn, R. S., Joëls, M., & Vinkers, C. H. (2017). Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology, 77, 25-36. https://doi.org/10.1016/j.psyneuen.2016.11.036
  77. Zubin, J., & Spring, B. (1977). Vulnerability: A new view of schizophrenia. Journal of Abnormal Psychology, 86(2), 103-126. https://doi.org/10.1037/0021-843X.86.2.103